Open an account

OKYO Pharma

OKYO · NASDAQ

$1.37−$0.03 (−2.14%)TodayMarket closed ·
Prev close $1.40

About OKYO

OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. The firm is focused on the discovery and development of novel molecules to treat neuropathic corneal pain and dry eye disease. Its research program focuses on a novel G Protein-Coupled Receptor (GPCR). The Company’s lead candidate, urcosimod, is a non-steroidal anti-inflammatory and non-opioid analgesic. Urcosimod consists of a 10-mer C-terminal Chemerin sequence, a linker (PEG-8), and Palmitic acid. The company has completed a Phase II trial in patients with DED and NCP. The firm also plans to evaluate its potential in benefiting patients with ocular neuropathic pain, uveitis and allergic conjunctivitis. The company is also evaluating OK-201, a bovine adrenal medulla (BAM), lipidated-peptide preclinical analogue candidate that is in the developmental stage.

Employees
4
Headquarters
London
Listed
Jul 17, 2018
Sector
Health Care
Industry
Biotechnology
Website
okyopharma.com

OKYO key statistics

Market cap
71.90M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
53.16K
Volume
50.68K
Open price
$1.41
High today
$1.42
Low today
$1.37
52 Week high
$3.20
52 Week low
$1.26

OKYO Pharma (OKYO) at a glance

As of Oct 20, 2026, OKYO Pharma (OKYO) shares are priced at $1.37, giving the company a market cap of 71.90M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.37 and $1.42. The current price is 0.0% above the day's low and 3.5% below its high.

Volume so far is 50.68K shares, in line with the average of 53.16K shares a day.

Over the past year OKYO Pharma has ranged from $1.26 to $3.20, and now sits 5% of the way up that range.

The average analyst price target is $8.50, 520.4% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $8.50
Low
$5.05
Now
$1.37
High
$13.65

OKYO news

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • 3 Health Care Stocks Moving In Thursday's Intraday Session

  • Avi Kapoor

    Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

  • Avi Kapoor

    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Similar companies

Companies in the same industry as OKYO Pharma

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.